Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
773.00    -11.50 (-1.47%)
Bid:
777.50
Ask:
778.00
Spread: 0.50 (0.064%)
Market Cap: £2.60b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

Share Buyback Programme

22 Oct 2024 07:00

RNS Number : 0313J
Drax Group PLC
22 October 2024
 

22 October 2024

 

DRAX GROUP PLC

(Symbol: DRX)

 

Share Buyback Programme

 

On 7 August 2024, Drax Group plc (the "Company") announced that in connection with the up to £300 million share buyback programme announced on 26 July 2024 (the "Programme"), it was commencing the first tranche of a share buyback programme to purchase ordinary shares of 11 16/29 pence each in the Company up to a maximum consideration of £75 million (the "First Tranche"). As at 21 October 2024, the Company had repurchased 9,031,476 shares for a consideration of c.£59 million. The First Tranche of the Programme is therefore over 75% completed.

 

The Company is today confirming that the second tranche of the Programme to purchase ordinary shares in the Company of up to a maximum consideration of £75 million (the "Second Tranche") will commence immediately following the conclusion of the First Tranche.

 

The purpose of the Second Tranche is to reduce the Company's share capital. The ordinary shares purchased by the Company will be held in treasury pending cancellation or re-issue.

 

Ordinary share purchases as part of the Second Tranche of the Programme will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volumes. The maximum number of shares that may be repurchased by the Company under the Second Tranche of the Programme is 29,436,781, being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the AGM on 25 April 2024 less the shares acquired under the First Tranche. The Company expects the required authority will be renewed at the AGM to be held in 2025.

 

The Company has entered into a non-discretionary agreement with RBC Europe Limited ("RBC") pursuant to which it has issued irrevocable instructions to RBC to conduct the Second Tranche of the Programme. RBC will carry out the Second Tranche of the Programme through the acquisition of ordinary shares in the Company within certain pre-defined parameters for subsequent repurchase by the Company. Any purchase of ordinary shares in the Company will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 (also as in force in the UK, from time to time, including, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as applicable laws and the regulations of the UK Financial Conduct Authority (including Chapter 9 of the UK Listing Rules).

 

The Company will make further announcements in due course following the buyback of shares. Note there is no guarantee that the Programme will be implemented in full.

 

Capitalised terms relate to the Company's announcement on 7 August 2024 unless specified otherwise.

 

Enquiries:

Drax Investor Relations: Mark Strafford

+44 (0) 7730 763 949

 

Media:

Drax External Communications: Andy Low

+44 (0) 7841 068415 

 

RBC Europe Limited:

James Agnew / Jack Wood

+44 (0) 20 7404 5959

 

Website: www.drax.com

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZMZGLMVGDZM
Date   Source Headline
3rd Oct 20221:38 pmRNSBlock listing Interim Review - SAYE
3rd Oct 20221:36 pmRNSBlock listing Interim Review - PSP
3rd Oct 20221:36 pmRNSBlock listing Interim Review - LTIP 2020
3rd Oct 20221:31 pmRNSBlock listing Interim Review - DSP
3rd Oct 20221:22 pmRNSTotal Voting Rights
3rd Oct 20227:00 amRNSAcquisition of Remaining Interest in Pellet JV
29th Sep 20229:00 amRNSAdditional Listing
13th Sep 20229:35 amRNSTotal Voting Rights
23rd Aug 20229:40 amRNSAdditional Listing
3rd Aug 20224:00 pmRNSAcquisition of 90,000 tonnes Canadian pellet plant
1st Aug 202211:46 amRNSTotal Voting Rights
26th Jul 20227:00 amRNSHalf-year Report
20th Jul 202211:43 amRNSNotice of Results
15th Jul 20224:48 pmRNSHolding(s) in Company
6th Jul 20225:46 pmRNSUpdated expectations for full year 2022
6th Jul 20225:41 pmRNSExtension of coal operations at request of UK Gov
1st Jul 202210:43 amRNSTotal Voting Rights
28th Jun 202211:30 amRNSNotice of Change to Director Details
6th Jun 20223:01 pmRNSTotal Voting Rights
17th May 202211:34 amRNSHolding(s) in Company
12th May 20229:00 amRNSAdditional Listing
4th May 202211:03 amRNSDirector/PDMR Shareholding
3rd May 20225:03 pmRNSTotal Voting Rights
27th Apr 20223:19 pmRNSResult of AGM
27th Apr 20227:00 amRNSTrading Update
26th Apr 202212:20 pmRNSHolding(s) in Company
19th Apr 202212:00 pmRNS2022 Performance Awards - EPS Condition
8th Apr 202211:13 amRNSBlock listing Interim Review - SAYE
8th Apr 202211:11 amRNSBlock listing Interim Review - PSP
8th Apr 202211:10 amRNSBlock listing Interim Review - LTIP 2020
8th Apr 202211:08 amRNSBlock listing Interim Review - DSP
6th Apr 20223:30 pmRNSDirector/PDMR Shareholding
6th Apr 20229:00 amRNSTotal Voting Rights
30th Mar 20229:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:00 amRNSDirector/PDMR Shareholding
17th Mar 20221:34 pmRNSMailing of Annual Report and Notice of AGM
16th Mar 20229:00 amRNSAdditional Listing
1st Mar 202212:39 pmRNSTotal Voting Rights
24th Feb 20227:00 amRNSAnnual Financial Report
23rd Feb 20229:00 amRNSCapacity Market Agreements
16th Feb 20222:40 pmRNSNotice of Results
7th Feb 20228:30 amRNSAdditional Listing
2nd Feb 20229:27 amRNSTotal Voting Rights
28th Jan 202212:25 pmRNSResult of audit tender
5th Jan 20228:30 amRNSAdditional Listing
4th Jan 20223:49 pmRNSTotal Voting Rights
22nd Dec 20213:05 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amRNSInvestment in BECCS FEED Study
14th Dec 20217:00 amRNSContracts to supply 2.8Mt of biomass
1st Dec 202112:19 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.